Office of clinical pharmacology-cultured cells stably expressing human form of NAV1 5 channel proteins for in vitro electrophysiology ION channel pharmacology project-other function

Ended Purchase Order Awarded

Contract number
HHSF223201610287P
Awardee
Awarding agency
Obligated
$24,000

Award facts

Contract value 100% obligated
$24,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20903, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to SB Drug Discovery LIMITED, a for-profit organization, to provide cultured cells stably expressing the human form of the NAV1.5 channel protein for use in in vitro electrophysiology and ion channel pharmacology projects. The contract has a ceiling value of $24,000.00 and was awarded on June 28, 2016 with a completion date of September 24, 2016. The award was not associated with any set-aside designation.

Quick answers

Who was awarded contract HHSF223201610287P?

HHSF223201610287P was awarded to SB Drug Discovery LIMITED by Food and Drug Administration (Department of Health and Human Services) on June 28, 2016.

How much is contract HHSF223201610287P worth?

The government has obligated $24,000 on HHSF223201610287P.

Was contract HHSF223201610287P competed?

The extent of competition for HHSF223201610287P was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login